Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "HR-QOL in Adults With Hemophilia B Treated With Fidanacogene Elaparvovec Gene Therapy"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Sylvia Mackensen
By
Insights from 2023 ASH Annual Meeting
FEATURING
Sylvia Mackensen
0 views
January 16, 2024
Comments 0
Login to view comments.
Click here to Login
Benign Hematology